Vanda Pharmaceuticals (VNDA) EBITDA Margin Growth (1y) (2011 - 2026)
Vanda Pharmaceuticals (VNDA) EBITDA Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,552.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1,049.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Vanda Pharmaceuticals | 318.71 Mn | 116.40 Mn | 48.56 Mn | -1,512.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,512.00 |
| Dec 31, 2025 | -5,120.00 |
| Sep 30, 2025 | -3,252.00 |
| Jun 30, 2025 | -5,311.00 |
| Mar 31, 2025 | -6,253.00 |
| Dec 31, 2024 | -366.00 |
| Sep 30, 2024 | -764.00 |
| Jun 30, 2024 | -1,388.00 |
| Mar 31, 2024 | -2,266.00 |
| Dec 31, 2023 | -2,595.00 |
| Sep 30, 2023 | -2,143.00 |
| Jun 30, 2023 | -1,160.00 |
| Mar 31, 2023 | 1,595.00 |
| Dec 31, 2022 | -242.00 |
| Sep 30, 2022 | -945.00 |
| Jun 30, 2022 | -1,284.00 |
| Mar 31, 2022 | -2,924.00 |
| Dec 31, 2021 | -275.00 |
| Sep 30, 2021 | 260.00 |
| Jun 30, 2021 | 347.00 |